Purification of a specific inhibitor of reverse transcriptase from human placenta.
Human placental extracts contain a factor which specifically and reversibly inhibits the reverse transcriptase of mammalian retroviruses. This placental inhibitor has been partially purified and characterized. It elutes at 0.1-0.2 M phosphate on hydroxyapatite chromatography and can be further purified by phosphocellulose chromatography where it elutes at 0.4 M KCl. By these purification procedures, specific activities of 40-70,000 units of inhibitor per mg of protein were obtained. The size of the inhibitor is about 60-65,000 daltons as estimated by velocity sedimentation. The inhibitor purified by these techniques selectively inhibits the activity of purified reverse transcriptase from Rauscher murine leukemia virus and baboon endogenous virus. It is substantially less active against the reverse transcriptase of avian myeloblastosis virus. The specificity of this inhibitor for mammalian enzymes and particularly for the human placental reverse transcriptase suggests that it plays a role in the regulation of DNA synthesis in human placental development.
D000818:Animals; D009189:Avian Myeloblastosis Virus / Q000201:enzymology; D002415:Cats; D002500:Centrifugation, Isopycnic; D002850:Chromatography, Gel; D005260:Female; D006801:Humans; D005256:Leukemia Virus, Feline / Q000201:enzymology; D008970:Molecular Weight; D010215:Papio; D010920:Placenta / Q000201:enzymology* / Q000382:microbiology; D011247:Pregnancy; D012194:RNA-Directed DNA Polymerase / Q000302:isolation & purification; D011925:Rauscher Virus / Q000201:enzymology; D012190:Retroviridae / Q000201:enzymology*; D018894:Reverse Transcriptase Inhibitors
D018894:Reverse Transcriptase Inhibitors; D012194:RNA-Directed DNA Polymerase